Journal Information
Vol. 56. Issue 2.
Pages 165-167 (1 February 2002)
Share
Share
Download PDF
More article options
Vol. 56. Issue 2.
Pages 165-167 (1 February 2002)
Full text access
Síndrome de activación del macrófago: un reto diagnóstico
Macrophage activation syndrome: a diagnostic challenge
Visits
19375
J.A. Soult Rubio
Corresponding author
jasoult@terra.es

Correspondencia: Unidad de Cuidados Intensivos de Pediatría. Hospital Infantil Virgen del Rocío. Avda. Manuel Siurot, s/n. 41013 Sevilla.
, V. García Bernabeu, M.J. Sánchez Álvarez, M. Muñoz Sáez, J.D. López Castilla, A. Tovaruela Santos
Unidad de Cuidados Intensivos Pediátricos. Hospital Infantil Universitario Virgen del Rocío. Sevilla
This item has received
Article information

El síndrome de activación del macrófago (SAM) o síndrome hemofagocítico es una enfermedad rara y con una alta morbimortalidad. Se encuentra incluido dentro de las histiocitosis de la clase II y se distinguen dos formas: una familiar y otra secundaria a enfermedades subyacentes.

El diagnóstico de SAM supone un verdadero reto y muchos casos no llegan a diagnosticarse ante mortem. Se presentan 2 casos de SAM asociados a infecciones por parvovirus B19 y virus de Epstein-Barr.

Palabras clave:
Síndrome de activación del macrófago
Parvovirus B19
Virus de Epstein-Barr

Macrophage activation syndrome, or hemophagocytic syndrome, is a rare disease with high morbidity and mortality. It is a disorder of the mononuclear phagocyte system. Two forms have been described; primary or familial hemophagocytic lymphohistiocytosis and secondary or sporadic hemophagocytic syndrome. Diagnosis of macrophage activation syndrome poses a real challenge for the pediatrician and in many cases is only made at autopsy. We describe two patients with hemophagocytic syndrome associated with parvovirus B19 and Epstein-Barr virus infection.

Key words:
Hemophagocytic syndrome
Parvovirus B19
Epstein-Barr virus
Full text is only aviable in PDF
Bibliografía
[1.]
A. Herrero, S. Ramírez, F. García, A. Martínez.
Síndromes hemofagocíticos.
An Esp Pediatr, 49 (1998), pp. 230-236
[2.]
J.I. Henter, G. Elinder.
Ost A and the FHL Study Group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis.
Semin Oncol, 18 (1991), pp. 29-33
[3.]
M. Arico, G. Janka, A. Fischer, J.I. Henter, S. Blanche, G. Elinder, et al.
Haemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society.
Leukemia, 10 (1996), pp. 197-203
[4.]
K. Shirono, H. Tsuda.
Parvovirus B19-associated haemophagocytic syndrome in healthy adults.
Br J Haematolog, 89 (1995), pp. 923-926
[5.]
K.R. Chundu, S. Lal, D.L. Bartley.
Multiple organ dysfunction caused by parvovirus B19.
West J Med, 163 (1995), pp. 574-576
[6.]
J.L. Stephan, J. Zeller, P. Hubert, C. Herbelin, J.M. Dayer, A.M. Prieur.
Macrophage activation syndrome and rheumatic disease in childhood: A report of four new cases.
Clin Exp Rheumatol, 11 (1993), pp. 451-456
[7.]
L. Tapia, B. Picazo, J. Romero, R. Díaz, F. Romero, J. Romero.
Síndrome de activación del macrófago secundario a enfermedad de Still.
An Esp Pediatr, 51 (1999), pp. 194-196
[8.]
D.C. Heaton, P.W. Moller.
Still’s disease associated with coxsackie infection and haemophagocytic syndrome.
Ann Rheum Dis, 44 (1985), pp. 341-344
[9.]
J.A. Morris, A.R. Adamson, P.J. Holt, J. Davson.
Still’s disease and the virus-associated haemophagocytic syndrome.
Ann Rheum Dis, 44 (1985), pp. 349-353
[10.]
M.S. Pallavi Metha.
Correspondence about elevated serum ferritin levels: Associated diseases and clinical significance.
Am J Med, 101 (1996), pp. 120-122
[11.]
R. Mouy, J.L. Stephan, P. Pillet, E. Haddad, P. Hubert, A.M. Prieru.
Efficacy of cyclosporine A in the treatment of machophage activation syndrome in juvenile arthritis: Report of five cases.
J Pediatr, 129 (1996), pp. 750-754
[12.]
R.L. Chen, K.H. Lin, D.T. Lin, I.J. Su, L.M. Huang, P.I. Lee, et al.
Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis.
Br J Haematol, 89 (1995), pp. 282-290
[13.]
N. Kimura, E. Ishii, M. Sako, T. Yoshida, M. Nagano, H. Takada, et al.
Effect of chemotherapy and stem cell transplantation on T lymphocyte clones in familial haemophagocytic lymphohistiocytosis.
Br J Haematol, 113 (2001), pp. 822-831
[14.]
S. Blanche, M. Caniglia, D. Girault, J. Landman, C. Griscelli, A. Fischer.
Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: A single center study of 22 cases.
Blood, 78 (1991), pp. 51-54
[15.]
M. Durken, M. Horstmann, P. Bieling, R. Erttmann, H. Kabisch, C. Loliger, et al.
Improved outcome in hemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: A single-centre experience of 12 patients.
Br J Haematol, 106 (1999), pp. 1052-1058
Copyright © 2002. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?